Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Curram

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Sexual Medicine|November 15, 2006
Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partnersDavid Edwards, Geoff Hackett, Owen Collins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 24, 2015
Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 studyDavid Langleben, Nazzareno Galiè, Jianguo He, et al.
Heart Asia|June 22, 2016
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparisonChen Wang, Zhi-Cheng Jing, Yi-Gao Huang, et al.
Annals of the Rheumatic Diseases|March 11, 2019
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohortWanlong Wu, Suzana Jordan, Nicole Graf, et al.
Annals of the Rheumatic Diseases|June 23, 2019
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisMike Becker, Nicole Graf, Rafael Sauter, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 28, 2015
Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 studyAndrea M D'Armini, Hossein-Ardeschir Ghofrani, Nick H Kim, et al.
Pulmonary Circulation|May 11, 2013
Advancing clinical trial design in pulmonary hypertensionAndy P Grieve, Shien-Chung Chow, John Curram, et al.
Stroke|April 21, 2007
The Virtual International Stroke Trials ArchiveMyzoon Ali, Philip M W Bath, John Curram, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Sexual Medicine|November 15, 2006
Vardenafil improves sexual function and treatment satisfaction in couples affected by erectile dysfunction (ED): a randomized, double-blind, placebo-controlled trial in PDE5 inhibitor-naïve men with ED and their partnersDavid Edwards, Geoff Hackett, Owen Collins, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 24, 2015
Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the phase III PATENT-1 studyDavid Langleben, Nazzareno Galiè, Jianguo He, et al.
Heart Asia|June 22, 2016
Riociguat for the treatment of pulmonary hypertension: Chinese subgroup analyses and comparisonChen Wang, Zhi-Cheng Jing, Yi-Gao Huang, et al.
Annals of the Rheumatic Diseases|March 11, 2019
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohortWanlong Wu, Suzana Jordan, Nicole Graf, et al.
Annals of the Rheumatic Diseases|June 23, 2019
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysisMike Becker, Nicole Graf, Rafael Sauter, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 28, 2015
Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 studyAndrea M D'Armini, Hossein-Ardeschir Ghofrani, Nick H Kim, et al.
Pulmonary Circulation|May 11, 2013
Advancing clinical trial design in pulmonary hypertensionAndy P Grieve, Shien-Chung Chow, John Curram, et al.
Stroke|April 21, 2007
The Virtual International Stroke Trials ArchiveMyzoon Ali, Philip M W Bath, John Curram, et al.
Pageof 1